Tetrahydrobiopterin (BH 4 ), is a pteridine product which is released by rodent macrophages and fibroblasts upon activation by cytokines. It has previously been reported as a potentially useful marker for monitoring immune activation during the prediabetic prodrome in the spontaneously diabetic BB rat. We have used serial serum BH4 measurements, first to confirm the hypothesis that serum BH4 is elevated as a result of immunostimulation, and second to monitor more closely the serum BH4 levels during the prediabetic prodrome in a cohort of diabetes prone BB rats. A modified biopterin radioimmunoassay protocol was used to establish a reference range of 25.5-80.1 nmolll (95% confidence limits) for 70 Wistar rats of mean age six months. When eight adult Wistar rats were treated with sic BCG there was a significant increase in serum BH4 level (p<O.Ol) which returned to pre-treatment levels by day 16, coincident with the disappearance of visible signs of inflammation. A cohort of 26 diabetes prone BB rats, their diabetes resistant controls (n=20) and a cohort of Wistar controls (n=20) were then used to monitor serum BH4 levels from 30-120 days of age, at frequent intervals. The diabetes incidence in the diabetes prone animals was 100% with a mean age of onset of 80 days. The serum tetrahydrobiopterin level was significantly higher at day 30 in all three groups (p< 0.05) than at any other time point. The serum BH4 level in the diabetes prone group was significantly higher at day 30 (p<O .Ol ) and day 60 (p<0.05) than in either control group. These results show that serum BH4 is a sensitive marker for immune activation following subcubaneous injection of BCG in the rat, and is detectable using RIA. Serum BH4 was maximum in this study at day 30, but the significantly higher levels at days 30 and 60 in the diabetes prone compared with the diabetes resistant animals suggest that the immune activation characteristic of prediabetes can be detected biochemically in blood samples.
Summary
Tetrahydrobiopterin (BH 4 ), is a pteridine product which is released by rodent macrophages and fibroblasts upon activation by cytokines. It has previously been reported as a potentially useful marker for monitoring immune activation during the prediabetic prodrome in the spontaneously diabetic BB rat. We have used serial serum BH4 measurements, first to confirm the hypothesis that serum BH4 is elevated as a result of immunostimulation, and second to monitor more closely the serum BH4 levels during the prediabetic prodrome in a cohort of diabetes prone BB rats. A modified biopterin radioimmunoassay protocol was used to establish a reference range of 25.5-80.1 nmolll (95% confidence limits) for 70 Wistar rats of mean age six months. When eight adult Wistar rats were treated with sic BCG there was a significant increase in serum BH4 level (p<O.Ol) which returned to pre-treatment levels by day 16, coincident with the disappearance of visible signs of inflammation. A cohort of 26 diabetes prone BB rats, their diabetes resistant controls (n=20) and a cohort of Wistar controls (n=20) were then used to monitor serum BH4 levels from 30-120 days of age, at frequent intervals. The diabetes incidence in the diabetes prone animals was 100% with a mean age of onset of 80 days. The serum tetrahydrobiopterin level was significantly higher at day 30 in all three groups (p< 0.05) than at any other time point. The serum BH4 level in the diabetes prone group was significantly higher at day 30 (p<O .Ol ) and day 60 (p<0.05) than in either control group. These results show that serum BH4 is a sensitive marker for immune activation following subcubaneous injection of BCG in the rat, and is detectable using RIA. Serum BH4 was maximum in this study at day 30, but the significantly higher levels at days 30 and 60 in the diabetes prone compared with the diabetes resistant animals suggest that the immune activation characteristic of prediabetes can be detected biochemically in blood samples.
Introduction
Insulin-Dependent Diabetes Mellitus (IDDM) is an autoimmune disease characterised by a local inflammatory reaction, or insulitis, which occurs in and around and pancreatic islets of Langerhans. The selective destruction of the beta cells which results is currently believed to be caused by activated immunocytes and the inflammatory cytokines they produce (1,2). It has been suggested that beta cell destruction continues at a linear rate from an initial trigger to the final appearance of symptoms ( 3) . Alternative hypotheses include a 'multi-hit' pattern of repeated exacerbations which ultimately lead to destruction ( 4), or a terminal, cytokine induced switch from THI to TH2 activity whereby a predominantly humoral responses in the islet infiltrate becomes acutely cytotoxic (5) . Interferon gamma (IFNy) is thought to be largely responsible for mediating the switch.
Studies on the spontaneously diabetic BB rat and NOD mouse of IDDM suggest that macrophages are the initial infiltrating cell type and that macrophage depletion can prevent both insulitis and diabetes itself ( 6) . Inflammatory cytokines, especially IFNy, induce the expression of inducible intric oxide synthase (EC 1.14. 13 . 39) in both immunocytes and endothelial cells, and the detrimental effect of nitric oxide on islet cell function and viability is currently believed to playa contributory role in their destruction (7) .
In addition to the induction of nitric oxide synthase, IFNy also induces expression of the enzyme GTP cyclohydrolase 1 (EC 3.5.4 .16) in macrophages, lymphocytes and fibroblasts (8) . GTP cyclohydrolase 1 is the first and, in rodents, the rate limiting enzyme in the de novo synthesis of tetrahydrobiopterin (BH 4 ), an obligate cofactor of nitric oxide synthase and of the aromatic amino acid hydroxylases. It has been proposed that the major function of immunostimulant invoked BH4 synthesis is primarily to support nitric oxide synthase activity (8) . Neopterin, the degradation product of dihydroneopterin triphosphate, an intermediate in the BH4 biosynthetic pathway, is well documented as a marker for IFNy stimulated immune activation in man and has been used to monitor cellular immune activation in transplantation, inflam.matory infections and malignant disease (9) . Elevated levels have been reported ill autoimmune diseases, including IDDM ( 10) .
In rodents, high expression of 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase, which converts dihydroneopterin triphosphate to BH 4 , leads to accumulation of BH4 itself rather than neopterin (11). Immune stimulated increases in BH4 have been documented both in vivo anJ in vitro (12, 13) . Davies et al (1994) (14) reported that a significant elevation in serum BH4 occurred late in the progression of prediabetes in a cohort of BB diabetes prone rats. Although the source of the serum BH4 was not established, its behaviour was consistent with acute immunoreactivity at, or just before, the time of diabetes onset. This observation was felt to be consistent with an acute terminal inflammatory event in the progression to IDDM. However, some of the diabetes prone animals in this study underwent repeated pancreatic biopsy, and serum sampling prior to diabetes onset was limited.
The aim of the present study was first to establish whether serum BH 4 , when measured by RIA, was sensitive to a recognised stimulus of immune activation and second, whether serum BH4 levels were able to detect the immune activation associated with prediabetes in diabetes prone BB rats.
Materials and Methods

Response to Bacillus Calmette-Gueran (BCG)
The UK animals (scientific procedures) act was adhered to at all times. Mixed mals and female Wistar rats were maintained on ordinary laboratory chow and tap water ad libitum, under a constant 12h light/dark cycle. Room temperature was a constant 22°C and humidity of 55+/ -10%. Eight adult animals aged 120 days each received 0.1 ml BCG intradermally at two sites. Eight controls received vehicle alone. The dose was repeated intradermally and subcutaneously, after which a visible flare was evident. Mixed venous/ arterial blood samples were obtained from the tail vein before the first dose was given and at intervals before and after subsequent challenges for determination of serum B~.
The BBIS rat colony
The BB rat colony at Southampton, designated BB/S to distinguish it from other inbred BB rat colonies, was derived from a thirtieth generation nucleus supplied by a commercial breeding centre (Mollegard Ltd, Ejby, Denmark) . Successive brother/sister mating has produced the BB/S diabetic prone and BB/S diabetic resistant sublines. At the time of these studies, the Southampton colony was in its fifth generation. The colony is maintained in a pathogen free environment in which handlers wear sterilised overalls, a filtered helmet and sterile gloves. The animals are fed on a breeding diet of irradiated rat chow (Bantin and Kingman, Hull. UK) and sterilised water ad libitum. Light was provided on a 14h/l0h light/dark cycle with the temperature maintained at 21°C. The animals were weighed daily and the urine analysed for glucose and ketones using Uristix (Ames, Stoke Poges, UK). If glycosuria was noted, the diagnosis of IDDM was confirmed the same day by blood glucose determination (>20 mmol/l) using BM sticks (Boehringer Mannheim Ltd, East Grinstead, UK). Diabetic rats were maintained on a single daily injection of subcutaneous bovine Ultralents, 40 IU /ml (Novo Nordisk, Bagsvaerd, Denmark), and the dose adjusted according to weight and degree of glycosuria.
Twenty six diabetic prone and 20 diabetic resistant animals from the Southampton colony were selected and studied from 30-120 days of age. Twenty control Wistar rats (the outbred strain from which the BB colony was originally derived) were similarly studied. Mixed venous/ arterial blood samples were obtained from the tail vein at 30, 60 and 120 days and at five day intervals between 75 and 105 days.
Tetrahydrobiopterin Radioimmunoassay
Total serum BH4 was determined using a modified protocol of the Biopterin Radioimmunoassay (15) kit kindly provided by Henning Berlin GmbH, Berlin, Germany (now Brahms Diagnostica GmbH)
A large percent of biopterin in body fluids exists as BH 4 . Acidic oxidation permits the determination of total biopterin. A 100 ~l sample of serum or standard was pipetted into a microfuge tube, to which was added 20 ~l of freshly prepared oxidising solution produced by adding 1.2 ml of 1 molar Hel to 400 mg manganese dioxide with thorough mixing to produce a homogenous suspension. After incubation in the dark for 10 mins with shaking, the reaction was terminated by the addition of 30 ~l 0.59 mol/I NaOH. After dilution with 350 ~ phosphate buffered saline and centrifugation at 10,000 g for 5 min, the supernatant was Pteridines/Vol. 9/No. 4 retained for biopterin estirnation.
One hundred microlitres at the oxidised serum or standard was mi..xed \\ith equal quantities of 1 125 labelled biopterin and a pre-precipitated antibiopterin antiserum and incubated for 2.5h in the dark. Wash solution, 1 ml, was added and the antigen-antibody complex separated by centrifugation for 10 min at 10,000 g. After aspiration, the precipitated counts were measured and the biopterin level calculated using a standard curve.
Using this modified protocol, serial serum dilutions showed parallelism with the standard curve. Two serum samples were spiked with commercial biopterin (Sigma Chemical Co., Poole, UK). Recovery varied from 64.5 to 112%. The inter-assay coefficient of variation for three points on the standard curve varied between 10.2 and 15.3%. The corresponding intra assay variation was between 5.3 and 11.2%. The assay sensitivity, based on the point 2.5 standard deviations above the mean of twenty replicates of the zero standard was 2.5 nmol/I. The mean binding coefficient, based on the maximum bound/total counts added and measured in ten assay runs was 45.2+/-4.14% (mean +/-SD). The serum BH4 levels measured using serum from 70 normal adult Wistar rats of mean age 6 months gave a mean value of 58.4 nmol/l with a range of 25.3-80.1 nmol/l (95% confidence limits).
Statistical Analysis
The serum BH4 concentrations for each group were compared using the paired Student's t-test. Differences between groups were considered significant for p<0.05.
Results
Response to BeG
A significant increase was seen in serum BH 4 , between two and twelve days after subcutaneous challenge with BCG when compared to vehicle alone. This coincided with visible evidence of a skin flare at the site of injection. By day 16 there was no significant difference between control and test groups (Table 1) .
Diabetes incidence in the BB rat colony
The mean age of onset of diabetes III the diabetes prone rats 'Yas 78 days, with 100% (26/ 
Serum biopterin levels
The mean serum BH4 concentrations at each time point for Wistar, diabetes prone and diabetes resistant BB rats are shown in Figure 1 . For all three groups the mean BH4 concentration at day 30 was significantly higher than at any other time point. For the diabetes prone group, the BH4 concentration at day 60 was also significantly higher than the remaining time points, though less strikingly so. When the serum BH4 concentrations were compared between test groups, they were significantly higher in the diabetes prone group at both day 30 and day 60 compared to both Wistar and diabetes resistant control groups. These results are summarised in Table 2. " ." 
Discussion
This series of experiments had two aims. First, to establish whether serum BH4 concentrations were a sensitive marker for immune activation in the rat, and second whether BH4 could detect any differences in immune reactivity between diabetes prone BB rats, their diabetes resistant BB controls and Wistar controls.
This study has dearly showed a highly significant (p<O .Ol ) response in serum BH4 to immunostimulation with subcutaneous BeG in normal adult Wistar rats. When rat macrophages (and fibroblasts) are activated by cytokiness, especially IFNy, GTP cydohydrolase 1, the first enzyme in the de novo biosynthetic pathway for the synthesis of BH4 from GTP is induced (8) . It is reasonable to assume that the source of the elevation in serum BH4 seen here is derived from macrophages, although other cell types could be involved. This is in agreement with previous studies showing increases in plasma BH4 in response to lipopolysaccharide (LPS) in vivo (16) . Both IFNy and BH4 were shown to increase in parallel in an experimental model of peritonitis and showed a significant correlation with the degree of endotoxinemia. In another study, LPS increased GTP cyclohydrolase 1 activity and BH4 levels in varlOUS rat tissues with concurrently increased plasma nitrate levels and a drop in systolic blood pressure, although increased plasma BH4 was not seen (17) . Davies et al ( 1994) suggested that BH4 may be a valuable marker of immune activation in the prediabetic period in the BB rat, showing a sharp elevation at or immediately prior to diabetes onset (14) . This previous study relied on only one time point around the time of diabetes incidence and 7 / 17 of the diabetes prone rats studied underwent repeated pancreatic biopsy. These animals were not subsequently returned to sterile conditions. We therefore sought to establish in more detail the pattern of serum BH4 excursions during the prediabetic period.
A large cohort of BB diabetes prone animals, their BB diabetes resistant controsl and a group of normal Wistar controls were included. The latter were included as BB diabetes resistant animals may show a diabetic blood glucose curve on testing and are metabolically abnormal in other ways, although they do not require insulin for survival (18) .
In all three groups, the serum BH4 level was significantly elevated at day 30, had dropped by day 60 and then stayed remarkably constant for the remainder of the study. In the diabetes prone group, the serum BH4 was significantly higher at both day 30 and 60 compared with both the control groups and with the remaining time points of the same group.
We can interpret this data in a number of ways. If the assumption that BH4 levels vary with IFN y mediated immunostimulation is correct, the results suggest that all three groups experience immunostimulation at the time of weaning (30 days of age) but that the diabetes prone group experiences a higher level of stimulation, which is still evident at day 60. Alternatively, the initial high level of BH4 could have another source.
Constitutive GTP cyclohydrolase aCllVlty is present in many cell types, where its main function is to supply BH4 as a cofactor for the aromatic amino acid h ydroA),lases ( 19) . GTP cyclohydrolase 1 activity shows an inverse relationship with age in rat erythrocytes, suggesting that its activity in reticulocytes is also high (20) . Experiments with phenylhydrazine, which stimulates the production of reticulocytes, increases both GTP cyclohydrolase 1 activity and BH4 itself BH4 may therefore play a role in the proliferation and dillerentiation of murine erythroid cells. A reciprocal relationship has been postulated, with the rate of de novo synthesis of BH4 high during periods of rapid proliferation of cells (21) .
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In humans, neopterin IS highly elevated in younger children and decreases with age. Biopterin increases from birth to 1-3 years and then decreases (22) . The inital high level of serum BH4 seen in all three test groups could therefore represent a normal developmental vanallon in serum BH4 at a time of rapid growth and development. Based on this assumption, the yet higher levels observed in the BB diabetes prone group could represent a more pronounced expression of the same effect. BB rats are unusually susceptible to the development of lymphoproliferative disorders related to the lymphopenia characteristic of these animals, and the elevation in serum BH4 could derive from disordered lymphoproliferation early in life (18) .
There was no significant difference in serum BH4 levels in the days imrnediatedly preceding diabetes incidence in the BB diabetes prone animals when compared either to other time points in the series or compared to the other test groups. This contrasts with the finding by Davies et al of a sharp and highly significant rise (p<.OOI) in serum BH4 in BB DP rats which was not seen in either BB DR or Wistar control groups (14) . This rise was interpreted as evidence of an acute terminal event in the tempo of prediabetic macrophage activation. In the present study, the sampling interval was increased to 5 days around the mean age of diabetes incidence, whereas Davies et al employed fixed 30 day intervals, which related variably to the day of onset. The most striking finding evident in Figure 1 is of the lack of variability in all three grous, with the serum BH4 level remarkably consistent from day 90 through to day 120. The half life of BH4 in vitro has been estimated to be just 6h ( 16) , suggesting that in vivo, BH4 levels are in a dynamic steady state maintained by rapid local biosynthesis. It is therefore unlikely, but not impossible for a significant increase to have occurred in the interval between time points. It is possible that our frequent sampling itself in some way prevented the BH4 response reported by Davies et al. The present results, however viewed, do not confirm an acute terminal event in the tempo of prediabetic immune activation.
It remains possible that the increase seen in BB diabetes prone animals at days 30 and 60 represents evidence of lffimune activation at this time.
In both BB and low dose streptozotocin models of IDDM, the first cells to infiltrate the islets are macrophages, followed by T helper cells same 30 days priar to' the anset af diabetes (18) . Light micrascapy studies shaw an initial lesian characterised by upregulatian af MHC class 1 malecules an the vascular endathelium and islet cells and a cellular infiltrate appearing 10-15 days later. The infiltrate cansists af dendritic cells and macraphages fallawed by helper T cells, cytotaxic T cells, NK cells and lastly B lymphacytes (23) . The histapathalagy af IDDM in the BB rat appears to' be divided intO' twa distinct phases, an initiatian phase characterised by antigen presentatian and recagnitian, endathelial and T cell activatian, and a perpetuatian and amplificatian phase in which an inflammatory infiltrate builds up (24) . Destructian af the beta cells is propased to' be due to' the release af cytakine-induced inflammatary mediators, such as nitric axide, axygen radicals and proteases.
If serum BH4 is viewed as a marker af cytakine mediated immunastimulatian, then a statistically significant increase at days 30 and 60 would imply that cytakine activation was accurring before the first af the events dacumented above have accurred. There seems to' be nO' ather published data to suppart such a suggestion in the BB rat. Early indicators af immune activity in very young children have detected changes as early as the first year of life (25 ) , althaugh the use of humaral markers of immune activity has nat praved useful in rodents.
The primary reasan for cytakine-mediated upregulatian af BH4 synthesis has been pastulated to' be to' supply the cafactar for induced nitric axide synthase activity, which is cainduced by the same stimuli. The need far an adequate supply af BH4 has been shawn for NOS activity in purified macrophage enzyme , and for intact cells, including macrophages, fibroblasts and muscle cells. Experiments in vivo using DAHP, an inhibitor af GTP cyclahydrolase I , ha\'e shO\\'n that limiting the availability of BH.; ma\' be a \'alid theraupeutic appraach to the selectiye inhibitian af iNOS (26) , althaugh aur O'wn initial obseryations with this campaund were that acute Gl tract taxicity resulted from its use at the required dase . If iNOS and BH4 are ca-induced in the region af the inflammatory infiltrate in IDDM, then the evidence here suggests that these lacalised increases are nat reflected in the serum BH4 level. BH4 binds to' N OS very tightly with a ~ af 0.2 ~M , and any increases in this case may remam localised to the tissue in question (27) .
In conclusion, we have shown that serum BH4 in the rat shows a statistically significant elevatian in respanse to immunastimulatian with subcutaneaus BCG, detectable by RIA.
The serum BH4 levels seen during the prediabetic prodrome in the BB rat are significantly elevated early, rather than late in the prediabetic period. The develapmental significance af this increase in the tempO' of the disease pracess remains a tapic tor further study.
